Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
3,593
Total Claims
$166K
Drug Cost
299
Beneficiaries
$556
Cost/Patient
Risk Score Breakdown 8/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+72%
Opioid rate vs peers
3.8% vs 2.2% avg
-61%
Cost per patient vs peers
$556 vs $1,411 avg
-12%
Brand preference vs peers
9.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.8%
Opioid Rate
138
Opioid Claims
$2,312
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 332 claims · $108K
Generic: 3,212 claims · $56K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 54 | $35K |
| Apixaban | 14 | $21K |
| Dabigatran Etexilate Mesylate | 28 | $8,201 |
| Fluticasone Propion/Salmeterol | 46 | $6,148 |
| Atorvastatin Calcium | 370 | $4,572 |
| Varicella-Zoster Ge/As01b/Pf | 17 | $3,196 |
| Levothyroxine Sodium | 139 | $2,965 |
| Insulin Nph Human Isophane | 11 | $2,631 |
| Amlodipine Besylate | 222 | $2,591 |
| Insulin Nph Human Isophane | 15 | $2,527 |
| Ciclesonide | 16 | $2,198 |
| Losartan Potassium | 143 | $1,710 |
| Pantoprazole Sodium | 113 | $1,693 |
| Metformin Hcl | 154 | $1,654 |
| Gabapentin | 89 | $1,616 |
Prescribing Profile
Patient Profile
72
Avg Age
66%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About